Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling.

[1]  R. Russell,et al.  A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. , 2002, Molecular cell.

[2]  T. Kodadek,et al.  Physical association of the APIS complex and general transcription factors. , 2002, Biochemical and biophysical research communications.

[3]  H. Hurst,et al.  Targeting of SWI/SNF chromatin remodelling complexes to estrogen‐responsive genes , 2002, The EMBO journal.

[4]  K. Yamamoto,et al.  Disassembly of Transcriptional Regulatory Complexes by Molecular Chaperones , 2002, Science.

[5]  D. DeFranco,et al.  Proteasomal Inhibition Enhances Glucocorticoid Receptor Transactivation and Alters Its Subnuclear Trafficking , 2002, Molecular and Cellular Biology.

[6]  G. Hager,et al.  ATP-Dependent Mobilization of the Glucocorticoid Receptor during Chromatin Remodeling , 2002, Molecular and Cellular Biology.

[7]  F. Gannon,et al.  Human estrogen receptor-α: regulation by synthesis, modification and degradation , 2002, Cellular and Molecular Life Sciences CMLS.

[8]  L. Freedman,et al.  Reciprocal Recruitment of DRIP/Mediator and p160 Coactivator Complexes in Vivo by Estrogen Receptor* , 2002, The Journal of Biological Chemistry.

[9]  Thomas Kodadek,et al.  Recruitment of a 19S Proteasome Subcomplex to an Activated Promoter , 2002, Science.

[10]  J. Qin,et al.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.

[11]  E. Alarid,et al.  Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-alpha. , 2002, American journal of physiology. Endocrinology and metabolism.

[12]  S. Saccani,et al.  Two Waves of Nuclear Factor κb Recruitment to Target Promoters , 2001, The Journal of experimental medicine.

[13]  B. Katzenellenbogen,et al.  Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.

[14]  J. Pietenpol,et al.  Kinetics of p53 Binding to Promoter Sites In Vivo , 2001, Molecular and Cellular Biology.

[15]  S. Nakashima,et al.  MDM2 Enhances the Function of Estrogen Receptor α in Human Breast Cancer Cells , 2001 .

[16]  Myles Brown,et al.  Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription , 2000, Cell.

[17]  Heike Brand,et al.  The 3'-Untranslated Region of the Human Estrogen Receptor α Gene Mediates Rapid Messenger Ribonucleic Acid Turnover. , 2000, Endocrinology.

[18]  G. Géraud,et al.  In mouse myoblasts nuclear prosomes are associated with the nuclear matrix and accumulate preferentially in the perinucleolar areas. , 2000, Journal of cell science.

[19]  B. O’Malley,et al.  The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation , 2000 .

[20]  Carolyn L. Smith,et al.  Subnuclear Trafficking of Estrogen Receptor-α and Steroid Receptor Coactivator-1 , 2000 .

[21]  Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. , 2000, Molecular endocrinology.

[22]  J. McNally,et al.  The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. , 2000, Science.

[23]  B. O’Malley,et al.  FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent , 2000, Nature Cell Biology.

[24]  E. Alarid,et al.  Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. , 1999, Molecular endocrinology.

[25]  M. O’Connor,et al.  The Human Papillomavirus Type 16 E6 Oncoprotein Can Down-Regulate p53 Activity by Targeting the Transcriptional Coactivator CBP/p300 , 1999, Journal of Virology.

[26]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.

[27]  N. McKenna,et al.  Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functionsProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998. , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  B. O’Malley,et al.  Proteasome-dependent degradation of the human estrogen receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[29]  The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily , 1999, Molecular and Cellular Biology.

[30]  D. Livingston,et al.  p300/MDM2 complexes participate in MDM2-mediated p53 degradation. , 1998, Molecular cell.

[31]  Wolfgang Baumeister,et al.  The Proteasome: Paradigm of a Self-Compartmentalizing Protease , 1998, Cell.

[32]  H. Gronemeyer,et al.  Reappraisal of the role of heat shock proteins as regulators of steroid receptor activity. , 1998, Critical reviews in biochemistry and molecular biology.

[33]  S. Lindquist,et al.  In vivo functions of the Saccharomyces cerevisiae Hsp90 chaperone. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[35]  J. Trowsdale,et al.  Dynamics of proteasome distribution in living cells , 1997, The EMBO journal.

[36]  John H. White,et al.  Selective Interaction of hsp90 with an Estrogen Receptor Ligand-binding Domain Containing a Point Mutation* , 1997, The Journal of Biological Chemistry.

[37]  B. Henderson,et al.  Estrogens and breast cancer. , 1996, Carcinogenesis.

[38]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[39]  H. Isom,et al.  Nuclear scaffold-associated protease: In situ nuclear localization and effects of a protease inhibitor on growth and morphology of a ras-transformed hepatocyte cell line , 1995 .

[40]  R. Thampan,et al.  Ubiquitination of the rat uterine estrogen receptor: dependence on estradiol. , 1995, Biochemical and biophysical research communications.

[41]  P. Webb,et al.  Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. , 1995, Molecular endocrinology.

[42]  D. Moore,et al.  Interaction of thyroid-hormone receptor with a conserved transcriptional mediator , 1995, Nature.

[43]  M. Parker,et al.  Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Nickerson,et al.  Core filaments of the nuclear matrix , 1990, The Journal of cell biology.

[45]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[46]  P. Chambon,et al.  Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. , 1982, Nucleic acids research.

[47]  E. Jensen,et al.  Estrogen-binding substances of target tissues. , 1969, Science.